Centessa Pharmaceuticals
(CNTA)
undefined
undefined%
At close: undefined
16.57
-0.06%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Cash & Equivalents | 128.03M | 393.64M | 595.08M | 7.23M |
Short-Term Investments | 128.52M | - | - | - |
Long-Term Investments | - | - | - | - |
Other Long-Term Assets | 2.55M | 45.98M | 34.39M | 552.00K |
Receivables | 39.15M | 26.72M | 16.81M | - |
Inventory | 1.00 | -29.99M | -17.81M | 1.00M |
Other Current Assets | 19.39M | 17.38M | 16.88M | 3.94M |
Total Current Assets | 315.09M | 393.64M | 595.08M | 11.16M |
Property-Plant & Equipment | 12.95M | 1.17M | 162.00K | - |
Goodwill & Intangibles | - | - | - | - |
Total Long-Term Assets | 45.15M | 50.66M | 34.55M | 552.00K |
Total Assets | 360.25M | 444.31M | 629.63M | 11.72M |
Account Payables | 11.81M | 13.84M | 7.30M | 1.03M |
Deferred Revenue | - | - | - | 1.04M |
Short-Term Debt | - | - | - | 5.63M |
Other Current Liabilities | 27.46M | 22.92M | 16.57M | 1.96M |
Total Current Liabilities | 39.38M | 38.34M | 24.64M | 8.62M |
Long-Term Debt | 84.59M | 69.80M | 75.70M | - |
Other Long-Term Liabilities | 29.00K | - | 37.74M | - |
Total Long-Term Liabilities | 84.62M | 108.14M | 138.08M | 25.52M |
Total Liabilities | 124.00M | 108.14M | 138.08M | 34.14M |
Total Debt | 84.59M | 69.80M | 75.70M | 5.63M |
Common Stock | 273.00K | 265.00K | 252.00K | 21.00K |
Retained Earnings | -752.95M | -601.86M | -385.65M | -22.42M |
Comprehensive Income | 1.49M | -1.50M | 688.00K | -86.00K |
Shareholders Equity | 236.24M | 336.17M | 491.55M | -22.42M |
Total Investments | 128.52M | - | - | - |